Literature DB >> 11063878

Ex vivo expansion of human umbilical cord blood and peripheral blood CD34(+) hematopoietic stem cells.

G L Gilmore1, D K DePasquale, J Lister, R K Shadduck.   

Abstract

The proliferation and expansion of human hematopoietic stem cells (HSC) in ex vivo culture was examined with the goal of generating a suitable clinical protocol for expanding HSC for patient transplantation.HSC were derived from umbilical cord blood (UCB) and adult patient peripheral blood stem cell collections. HSC were stimulated to proliferate ex vivo by a combination of two growth factors, flt-3 ligand (FL) and thrombopoietin/c-mpl ligand (TPO/ML), and assessed for expansion by flow cytometry.Ex vivo expansion cultures of UCB were maintained for prolonged periods (up to 16 weeks), and sufficient HSC were generated for adult transplantation. In contrast to UCB, FL + TPO/ML did not significantly increase CD34(+) peripheral blood stem cell (PBSC) numbers.UCB-HSC can be expanded in culture to numbers theoretically adequate for safe, rapid engraftment of adult patients. Additional studies are needed to establish the functional activity of expanded UCB-HSC.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11063878     DOI: 10.1016/s0301-472x(00)00531-2

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  13 in total

1.  Pilot social feasibility study for the establishment of a public human umbilical cord blood stem cell bank in South Africa.

Authors:  Madelein Meissner-Roloff; Wendy Young; Isabella Rangaka; Hennie Lombaard; Ames Dhai; Norma Tsotsi; Michael S Pepper
Journal:  Stem Cell Rev Rep       Date:  2012-12       Impact factor: 5.739

2.  Long-term self-renewal of postnatal muscle-derived stem cells.

Authors:  B M Deasy; B M Gharaibeh; J B Pollett; M M Jones; M A Lucas; Y Kanda; J Huard
Journal:  Mol Biol Cell       Date:  2005-05-04       Impact factor: 4.138

Review 3.  Potential for access to embryonic-like cells from human umbilical cord blood.

Authors:  C P McGuckin; N Forraz
Journal:  Cell Prolif       Date:  2008-02       Impact factor: 6.831

Review 4.  Concise review: ex vivo expansion of cord blood-derived hematopoietic stem and progenitor cells: basic principles, experimental approaches, and impact in regenerative medicine.

Authors:  Patricia Flores-Guzmán; Verónica Fernández-Sánchez; Hector Mayani
Journal:  Stem Cells Transl Med       Date:  2013-10-07       Impact factor: 6.940

Review 5.  Promising new sources for pluripotent stem cells.

Authors:  Christian Leeb; Marcin Jurga; Colin McGuckin; Richard Moriggl; Lukas Kenner
Journal:  Stem Cell Rev Rep       Date:  2010-03       Impact factor: 5.739

6.  CRISPR/Cas9 Targeted Gene Editing and Cellular Engineering in Fanconi Anemia.

Authors:  Mark Osborn; Cara-Lin Lonetree; Beau R Webber; Dharmeshkumar Patel; Samantha Dunmire; Amber N McElroy; Anthony P DeFeo; Margaret L MacMillan; John Wagner; Bruce R Balzar; Jakub Tolar
Journal:  Stem Cells Dev       Date:  2016-08-18       Impact factor: 3.272

7.  Thrombopoietin, flt3-ligand and c-kit-ligand modulate HOX gene expression in expanding cord blood CD133 cells.

Authors:  C P McGuckin; N Forraz; R Pettengell; A Thompson
Journal:  Cell Prolif       Date:  2004-08       Impact factor: 6.831

8.  Cell-cell interaction networks regulate blood stem and progenitor cell fate.

Authors:  Daniel C Kirouac; Gerard J Madlambayan; Mei Yu; Edward A Sykes; Caryn Ito; Peter W Zandstra
Journal:  Mol Syst Biol       Date:  2009-07-28       Impact factor: 11.429

9.  Expansion of CD133(+) Umbilical Cord Blood Derived Hematopoietic Stem Cells on a Biocompatible Microwells.

Authors:  Mina Soufizomorrod; Masoud Soleimani; Abbas Hajifathali; Majid Mossahebi Mohammadi; Saeed Abroun
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2013

10.  A small-molecule/cytokine combination enhances hematopoietic stem cell proliferation via inhibition of cell differentiation.

Authors:  Lan Wang; Xin Guan; Huihui Wang; Bin Shen; Yu Zhang; Zhihua Ren; Yupo Ma; Xinxin Ding; Yongping Jiang
Journal:  Stem Cell Res Ther       Date:  2017-07-18       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.